Thorne Healthtech Inc
NASDAQ:THRN
Thorne Healthtech Inc
Cost of Revenue
Thorne Healthtech Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Thorne Healthtech Inc
NASDAQ:THRN
|
Cost of Revenue
-$113.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Estee Lauder Companies Inc
NYSE:EL
|
Cost of Revenue
-$4.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
B
|
Bellring Brands Inc
NYSE:BRBR
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
Coty Inc
NYSE:COTY
|
Cost of Revenue
-$2.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Cost of Revenue
-$582.4m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-10%
|
|
elf Beauty Inc
NYSE:ELF
|
Cost of Revenue
-$264.1m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
See Also
What is Thorne Healthtech Inc's Cost of Revenue?
Cost of Revenue
-113.8m
USD
Based on the financial report for Dec 31, 2022, Thorne Healthtech Inc's Cost of Revenue amounts to -113.8m USD.
What is Thorne Healthtech Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-25%
Over the last year, the Cost of Revenue growth was -29%. The average annual Cost of Revenue growth rates for Thorne Healthtech Inc have been -25% over the past three years .